Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 7712 record(s)

Req # A-2019-000355

Adverse Reaction Report (AER). Report numbers: E2B_01506091, E2B_01536410, E2B_01507752, E2B_01630901, E2B_01504464, E2B_01502033, E2B_01570261, E2B_01568710, E2B_01787428, E2B_01692348.

Organization: Health Canada

249 page(s)
January 2020

Req # A-2019-000375

Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_01533867, E2B_01535930, E2B_01540756, E2B_01521256, 000707208, E2B_01633045, E2B_01548336, E2B_01636988, E2B_01549175, E2B_01587299, E2B_01511665, E2B_01521626, E2B_01553112, E2B_01556253, E2B_01557172, E2B_01563832.

Organization: Health Canada

254 page(s)
January 2020

Req # A-2019-000405

Reviewer reports & memos related to Implanon(Nexplanon) Submission.

Organization: Health Canada

25 page(s)
January 2020

Req # A-2019-000662

Adverse Reaction Report (AER). Report numbers: E2B_00037737, 000451377, 000605325, E2B_01076834, E2B_00910840, E2B_00910843, E2B_01420166.

Organization: Health Canada

82 page(s)
January 2020

Req # A-2019-000776

Adverse Reaction Report (AER). Report numbers: 000582143, E2B_01921293, E2B_01923546, E2B_00348966, 000655512, 000656009, E2B_02224126.

Organization: Health Canada

105 page(s)
January 2020

Req # A-2019-000816

Adverse Reaction Report (AER). Report number: E2B_02495972.

Organization: Health Canada

11 page(s)
January 2020

Req # A-2019-000832

Adverse Reaction Report (AER). Report numbers: E2B_00545500, E2B_00326364, E2B_00083473, E2B_00412320, 000619055 E2B_00555758, E2B_00559528, E2B_00559529, E2B_00559522, E2B_00559532, E2B_01198113.

Organization: Health Canada

209 page(s)
January 2020

Req # A-2019-000854

Adverse Reaction Report (AER). Report numbers: 000492716, E2B_00159834, E2B_00198472, 000662673, E2B_00772913, 000676355, E2B_00538219, 000716786, E2B_00019924, E2B_00303232.

Organization: Health Canada

123 page(s)
January 2020

Req # A-2019-000866

Adverse Reaction Report (AER). Report numbers: 000684536, E2B_02211326, E2B_02211319, E2B_01276404, 000533503, E2B_00560777, 000648689, E2B_00257768, E2B_00519627, E2B_00216159, E2B_01691011.

Organization: Health Canada

280 page(s)
January 2020

Req # A-2019-000869

Adverse Reaction Report (AER). Report numbers: E2B_01612791, E2B_01336327, 000646153, 000654731, E2B_00392629, E2B_00859505, E2B_00759476, E2B_00757946, E2B_00416048, 000696303, E2B_00014627, E2B_00817053, E2B_00817642, E2B_01785727, E2B_01518084.

Organization: Health Canada

216 page(s)
January 2020
Date modified: